Journal
Evidence-led overviews of the most studied research peptides: GLP-1 and amylin analogues such as semaglutide, tirzepatide and retatrutide, recovery peptides including BPC-157, TB-500 and GHK-Cu, and growth hormone secretagogues such as CJC-1295 and ipamorelin.
We explain mechanisms, what clinical and preclinical studies have actually found and where the evidence is still thin. Rogue’s peptides are sold for research purposes only and are not for human consumption.
Peptide Research
Few research compounds have moved from specialist journals into gym conversation as quickly as BPC-157 and TB-500. One is a fifteen-amino-acid fragment…
Read article
Peptide Research
Few questions in metabolic science have moved as fast as semaglutide vs tirzepatide. In barely half a decade, two engineered peptides have…
Read article
